Showing results (21-30 of 93) with videos related to
Sort By:
Pageof 10
Current Medical Research and Opinion|January 26, 2018
The prevalence of hyperkalemia in the United StatesKeith A Betts, J Michael Woolley, Fan Mu, et al.Crohn'S & Colitis 360|May 16, 2024
Real-World Patterns and Economic Burden Associated With Treatment Failure With Advanced Therapies in Patients With Moderate-to-Severe Ulcerative ColitisScott D Lee, Keith A Betts, Ella Xiaoyan Du, et al.Rheumatology and Therapy|October 18, 2016
Network Meta-Analysis and Cost Per Responder of Tumor Necrosis Factor-α and Interleukin Inhibitors in the Treatment of Active Ankylosing SpondylitisKeith A Betts, Jenny Griffith, Yan Song, et al.The American Journal of Managed Care|December 8, 2021
Medical costs for managing chronic kidney disease and related complications in patients with chronic kidney disease and type 2 diabetesKeith A Betts, Jinlin Song, Elizabeth Faust, et al.Clinical Therapeutics|July 24, 2017
Systematic Literature Review and Meta-analysis of Tumor Necrosis Factor-Alpha Experienced Rheumatoid ArthritisAlvin F Wells, Jeffrey R Curtis, Keith A Betts, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 7, 2018
Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized TrialsKim A Papp, Min Yang, Murali Sundaram, et al.Dermatology and Therapy|March 31, 2021
Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysisApril W Armstrong, Ahmed M Soliman, Keith A Betts, et al.Current Medical Research and Opinion|May 28, 2020
Prevalence and economic burden of hyperkalemia in the United States Medicare populationFan Mu, Keith A Betts, J Michael Woolley, et al.Kidney International Reports|August 11, 2020
Postdischarge Health Care Costs and Readmission in Patients With Hyperkalemia-Related HospitalizationsKeith A Betts, J Michael Woolley, Fan Mu, et al.Journal of Comparative Effectiveness Research|January 4, 2024
Comparative effectiveness of erenumab versus rimegepant for migraine prevention using matching-adjusted indirect comparisonRonan Mahon, Santosh Tiwari, Mirja Koch, et al.Pageof 10